Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cocoa Flavanols for Surgical Recovery
NCT03123068Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Stanford University. Primary endpoint: NFkB Signaling in Innate Immune Cells. Started Apr 2017; status: completed.
Beyond the preview
Go deeper on NCT03123068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123068.